{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T06:15:46Z","timestamp":1777875346746,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["26237"],"award-info":[{"award-number":["26237"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["25945"],"award-info":[{"award-number":["25945"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.bbadis.2025.168014","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T15:07:45Z","timestamp":1754665665000},"page":"168014","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Synergistic effects of oncogene inhibition and pyruvate dehydrogenase kinase blockade in resistant NSCLC cells"],"prefix":"10.1016","volume":"1871","author":[{"given":"Luisa","family":"Amato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina","family":"De Rosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Omodei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilla C.","family":"Tufano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rossella","family":"Buono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Concetta","family":"Tuccillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni N.","family":"Roviello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Spinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Fontanarosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Papaccio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Camerlingo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Floriana","family":"Morgillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Carpentieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Amoresano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia","family":"Tirino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Iommelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carminia Maria Della","family":"Corte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvana","family":"Del Vecchio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viviana","family":"De Rosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2025.168014_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.111079","article-title":"Breakthrough in targeted therapy for non-small cell lung cancer","volume":"133","author":"Ye","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbadis.2025.168014_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15205079","article-title":"New generations of tyrosine kinase inhibitors in treating NSCLC with oncogene addiction: strengths and limitations","volume":"15","author":"Attili","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbadis.2025.168014_bb0015","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1001\/jamaoncol.2015.1066","article-title":"Acquired resistance of EGFR-mutant lung cancer to a T790M-specific EGFR inhibitor: emergence of a third mutation (C797S) in the EGFR tyrosine kinase domain","volume":"1","author":"Yu","year":"2015","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.bbadis.2025.168014_bb0020","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/s41598-023-50568-5","article-title":"ITGB1 and DDR activation as novel mediators in acquired resistance to osimertinib and MEK inhibitors in EGFR-mutant NSCLC","volume":"14","author":"De Rosa","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2025.168014_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113959","article-title":"The prospect of combination therapies with the third-generation EGFR-TKIs to overcome the resistance in NSCLC","volume":"156","author":"Li","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbadis.2025.168014_bb0030","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nrc2981","article-title":"Regulation of cancer cell metabolism","volume":"11","author":"Cairns","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbadis.2025.168014_bb0035","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2025.168014_bb0040","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2025.168014_bb0045","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaw5473","article-title":"Metabolic reprogramming and cancer progression","volume":"368","author":"Faubert","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2025.168014_bb0050","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2025.168014_bb0055","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.124.3215.269","article-title":"On respiratory impairment in cancer cells","volume":"124","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2025.168014_bb0060","doi-asserted-by":"crossref","first-page":"5110","DOI":"10.1158\/1078-0432.CCR-15-0375","article-title":"Reversal of Warburg effect and reactivation of oxidative phosphorylation by differential inhibition of EGFR signaling pathways in non-small cell lung cancer","volume":"21","author":"De Rosa","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbadis.2025.168014_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20133134","article-title":"Coordinate modulation of glycolytic enzymes and OXPHOS by Imatinib in BCR-ABL driven chronic myelogenous leukemia cells","volume":"20","author":"De Rosa","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2025.168014_bb0070","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13550-016-0229-0","article-title":"Early 18F-FDG uptake as a reliable imaging biomarker of T790M-mediated resistance but not MET amplification in non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors","volume":"6","author":"De Rosa","year":"2016","journal-title":"EJNMMI Res."},{"key":"10.1016\/j.bbadis.2025.168014_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13164133","article-title":"Non-canonical role of PDK1 as a negative regulator of apoptosis through macromolecular complexes assembly at the ER-mitochondria Interface in oncogene-driven NSCLC","volume":"13","author":"De Rosa","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbadis.2025.168014_bb0080","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djx071","article-title":"Therapeutic targeting of the pyruvate dehydrogenase complex\/pyruvate dehydrogenase kinase (PDC\/PDK) Axis in cancer","volume":"109","author":"Stacpoole","year":"2017","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bbadis.2025.168014_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2023.166769","article-title":"Regulating mitochondrial metabolism by targeting pyruvate dehydrogenase with dichloroacetate, a metabolic messenger","volume":"1869","author":"Schoenmann","year":"2023","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.bbadis.2025.168014_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16233941","article-title":"Combined therapeutic strategies based on the inhibition of non-oncogene addiction to improve tumor response in EGFR- and KRAS-mutant non-small-cell lung cancer","volume":"16","author":"Amato","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbadis.2025.168014_bb0095","doi-asserted-by":"crossref","first-page":"W365","DOI":"10.1093\/nar\/gkx407","article-title":"HDOCK: a web server for protein-protein and protein-DNA\/RNA docking based on a hybrid strategy","volume":"45","author":"Yan","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbadis.2025.168014_bb0100","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1038\/s41596-020-0312-x","article-title":"The HDOCK server for integrated protein-protein docking","volume":"15","author":"Yan","year":"2020","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bbadis.2025.168014_bb0105","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s40097-023-00523-7","article-title":"Self-assembly of thyminyl l-tryptophanamide (TrpT) building blocks for the potential development of drug delivery nanosystems","volume":"14","author":"Scognamiglio","year":"2024","journal-title":"J. Nanostructure Chem."},{"key":"10.1016\/j.bbadis.2025.168014_bb0110","doi-asserted-by":"crossref","first-page":"12865","DOI":"10.1039\/D1NR02687A","article-title":"Interaction of serum proteins with SARS-CoV-2 RBD","volume":"13","author":"Yin","year":"2021","journal-title":"Nanoscale"},{"key":"10.1016\/j.bbadis.2025.168014_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/biom14050579","article-title":"BSA binding and aggregate formation of a synthetic amino acid with potential for promoting fibroblast proliferation: an in silico, CD spectroscopic, DLS, and cellular study","volume":"14","author":"Simonyan","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.bbadis.2025.168014_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph19052502","article-title":"The healing power of clean rivers: in silico evaluation of the antipsoriatic potential of apiin and hyperoside plant metabolites contained in river waters","volume":"19","author":"Roviello","year":"2022","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.bbadis.2025.168014_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/biom12081071","article-title":"CD, UV, and in silico insights on the effect of 1,3-bis(1\u2032-uracilyl)-2-propanone on serum albumin structure","volume":"12","author":"Greco","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.bbadis.2025.168014_bb0130","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","article-title":"UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses","volume":"19","author":"Chandrashekar","year":"2017","journal-title":"Neoplasia"},{"key":"10.1016\/j.bbadis.2025.168014_bb0135","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2025.168014_bb0140","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bbadis.2025.168014_bb0145","doi-asserted-by":"crossref","first-page":"7277","DOI":"10.1158\/0008-5472.CAN-13-1868","article-title":"Combined targeting of PDK1 and EGFR triggers regression of glioblastoma by reversing the Warburg effect","volume":"73","author":"Velpula","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2025.168014_bb0150","doi-asserted-by":"crossref","first-page":"22700","DOI":"10.1074\/jbc.M801765200","article-title":"Pyruvate dehydrogenase complex activity controls metabolic and malignant phenotype in cancer cells","volume":"283","author":"McFate","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2025.168014_bb0155","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.ejphar.2016.08.004","article-title":"Anti-cancer synergy of dichloroacetate and EGFR tyrosine kinase inhibitors in NSCLC cell lines","volume":"789","author":"Yang","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbadis.2025.168014_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13050941","article-title":"Blocking aerobic glycolysis by targeting pyruvate dehydrogenase kinase in combination with EGFR TKI and ionizing radiation increases therapeutic effect in non-small cell lung cancer cells","volume":"13","author":"Dyrstad","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbadis.2025.168014_bb0165","article-title":"Integration of molecular docking and in vitro studies: a powerful approach for drug discovery in breast cancer","volume":"10","author":"Cava","year":"2020","journal-title":"Appl. Sci. Basel"},{"key":"10.1016\/j.bbadis.2025.168014_bb0170","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.2174\/1570180820666221111151104","article-title":"Role of docking in anticancer drug discovery","volume":"20","author":"Alavi","year":"2023","journal-title":"Lett. Drug Des. Discov."},{"key":"10.1016\/j.bbadis.2025.168014_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13092022","article-title":"A reversible shift of driver dependence from EGFR to Notch1 in non-small cell lung cancer as a cause of resistance to tyrosine kinase inhibitors","volume":"13","author":"Iommelli","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbadis.2025.168014_bb0180","doi-asserted-by":"crossref","first-page":"4806","DOI":"10.1158\/1078-0432.CCR-14-0264","article-title":"Monitoring reversal of MET-mediated resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer using 3\u2032-deoxy-3\u2032-[18F]-fluorothymidine positron emission tomography","volume":"20","author":"Iommelli","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbadis.2025.168014_bb0185","doi-asserted-by":"crossref","first-page":"5224","DOI":"10.1158\/1078-0432.CCR-08-3270","article-title":"Imaging of alpha(v)beta(3) expression by a bifunctional chimeric RGD peptide not cross-reacting with alpha(v)beta(5)","volume":"15","author":"Zannetti","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbadis.2025.168014_bb0190","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/s41418-019-0474-7","article-title":"Autophagy in cancer: moving from understanding mechanism to improving therapy responses in patients","volume":"27","author":"Mulcahy Levy","year":"2020","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbadis.2025.168014_bb0195","doi-asserted-by":"crossref","first-page":"11542","DOI":"10.1002\/cam4.5577","article-title":"Autophagy: a challengeable paradox in cancer treatment","volume":"12","author":"Ahmadi-Dehlaghi","year":"2023","journal-title":"Cancer Med."},{"key":"10.1016\/j.bbadis.2025.168014_bb0200","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/s41392-020-00313-5","article-title":"Emerging role of tumor cell plasticity in modifying therapeutic response","volume":"5","author":"Qin","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbadis.2025.168014_bb0205","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s10637-013-0047-4","article-title":"Phase 1 trial of dichloroacetate (DCA) in adults with recurrent malignant brain tumors","volume":"32","author":"Dunbar","year":"2014","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.bbadis.2025.168014_bb0210","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1212\/01.wnl.0000196641.05913.27","article-title":"Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial","volume":"66","author":"Kaufmann","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2025.168014_bb0215","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8201079","article-title":"Dichloroacetate (DCA) and cancer: an overview towards clinical applications","volume":"2019","author":"Tataranni","year":"2019","journal-title":"Oxidative Med. Cell. Longev."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092544392500362X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092544392500362X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T21:37:23Z","timestamp":1777585043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092544392500362X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S092544392500362X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2025.168014","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synergistic effects of oncogene inhibition and pyruvate dehydrogenase kinase blockade in resistant NSCLC cells","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2025.168014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"168014"}}